please do answer all of the question, thank you! : IV. SARS COV-2 and COVID-19: Where We Are Then and NowDirections: Read an excerpt from a Department of Health (DOH) article on COVID-19 Disease. Then answer the questions that follow.BACKGROUNDThe novel coronavirus, SARS COV-2, first isolated in Wuhan City, Hubei province, in Chinalast December 2019, has caused a global pandemic with staggering speed. As of June 30,2020, there were more than 10,000,000 COVID-19 cases worldwide, with more than500,000 reported deaths...The situation in the Philippines has also rapidly evolved, with a single case identified lastJanuary 30, 2020, to over 200 cases by March 16, 2020...The clinical presentation of COVID-19 disease ranges from a mild common cold-likeillness to a severe viral pneumonia leading to acute respiratory distress syndrome that ispotentially fatal. Large, retrospective case series from China have shown that the elderly,those with comorbidities, and those with pneumonia are most at risk for severe disease (3-6). The predominant mode of transmission remains person to person spread viarespiratory droplets. The peak of infectiousness is just before or within 5 days of symptomonset. The main driver of transmission remains the symptomatic group althoughpresymptomatics and asymptomatics may transmit the disease but to a lesser extent.Treatment is largely supportive, although in-vitro and early observational data regardingthe off-label use of several re-purposed drugs, such as remdesivir, chloroquine,hydroxychloroquine, lopinavir-ritonavir and tocilizumab showed some promise. Variouspharmacologic and nonpharmacologic interventions are being investigated in a clinical trialor given as compassionate use. Supportive care and intensive respiratory managementremain the standard of care for COVID-19... 4. Whom would most likely spread COVID-19- anansymptomatic person?VID-19-an asyasymptomatic person or aasympt5. When this article was published, what kind of treatment was only available? Today,what kind of preventive measure is available?6. If you or the members of your family have not received such preventive measure,how do you protect yourself from this deadly COVID-19?7. Recent studies show that many people who have been infected with the viruscausing COVID-19 develop antibodies specific to this virus. What system or systemsare involved in the production of antibodies?8. With the preventive measure available to combat COVID-19, the term, "herdimmunity" is often used. What is herd or population immunity? How is it achieved?

Question

please do answer all of the question, thank you! :> IV. SARS COV-2 and COVID-19: Where We Are Then and NowDirections: Read an excerpt from a Department of Health (DOH) article on COVID-19 Disease. Then answer the questions that follow.BACKGROUNDThe novel coronavirus, SARS COV-2, first isolated in Wuhan City, Hubei province, in Chinalast December 2019, has caused a global pandemic with staggering speed. As of June 30,2020, there were more than > 10,000,000 COVID-19 cases worldwide, with more than500,000 reported deaths...The situation in the Philippines has also rapidly evolved, with a single case identified lastJanuary 30, 2020, to over 200 cases by March 16, 2020...The clinical presentation of COVID-19 disease ranges from a mild common cold-likeillness to a severe viral pneumonia leading to acute respiratory distress syndrome that ispotentially fatal. Large, retrospective case series from China have shown that the elderly,those with comorbidities, and those with pneumonia are most at risk for severe disease (3-6). The predominant mode of transmission remains person to person spread viarespiratory droplets. The peak of infectiousness is just before or within 5 days of symptomonset. The main driver of transmission remains the symptomatic group althoughpresymptomatics and asymptomatics may transmit the disease but to a lesser extent.Treatment is largely supportive, although in-vitro and early observational data regardingthe off-label use of several re-purposed drugs, such as remdesivir, chloroquine,hydroxychloroquine, lopinavir-ritonavir and tocilizumab showed some promise. Variouspharmacologic and nonpharmacologic interventions are being investigated in a clinical trialor given as compassionate use. Supportive care and intensive respiratory managementremain the standard of care for COVID-19... 4. Whom would most likely spread COVID-19- anansymptomatic person?VID-19-an asyasymptomatic person or aasympt5. When this article was published, what kind of treatment was only available? Today,what kind of preventive measure is available?6. If you or the members of your family have not received such preventive measure,how do you protect yourself from this deadly COVID-19?7. Recent studies show that many people who have been infected with the viruscausing COVID-19 develop antibodies specific to this virus. What system or systemsare involved in the production of antibodies?8. With the preventive measure available to combat COVID-19, the term, &#34;herdimmunity&#34; is often used. What is herd or population immunity? How is it achieved?

Accepted Answer

Introduction :
The SARS-CoV-2 virus is the infectious agent that causes the disease known as…

4. Whom would most likely spread COVID-19- an asymptomatic person or a symptomatic person?